phenylalanine has been researched along with Dysmyelopoietic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caceres, G; Dewald, DW; List, AF; Rocha, K; Sokol, L; Stockero, KJ | 1 |
| Aguilar, JL; Baumann, T; Calvo, X; Cervantes, F; Colomer, D; Costa, D; Díaz-Beyá, M; Esteve, J; Maffioli, M; Martínez-Trillos, A; Nomdedeu, B; Nomdedeu, M; Rozman, M | 1 |
2 other study(ies) available for phenylalanine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
JAK2(V617F) mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones.
Topics: Amino Acid Substitution; Chromosome Deletion; Chromosomes, Human, Pair 5; Clone Cells; Erythroid Precursor Cells; Female; Humans; Janus Kinase 2; Middle Aged; Mutation, Missense; Myelodysplastic Syndromes; Phenylalanine; Valine | 2010 |
Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation.
Topics: Amino Acid Substitution; Anemia, Macrocytic; Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Female; Humans; Janus Kinase 2; Lenalidomide; Middle Aged; Mutation, Missense; Myelodysplastic Syndromes; Phenylalanine; Thalidomide; Treatment Outcome; Valine | 2011 |